Phocas Financial »

Protagonist Therapeutics shares owned by Phocas Financial

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Phocas Financial from 13F filings

Historical chart of Phocas Financial investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Phocas Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Phocas Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 16k 122.58

More positions owned by Phocas Financial

Ducommun Incorporated (DCO)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Aar (AIR)
Materion Corporation (MTRN)
Stonex Group (SNEX)
Ralliant Corp (RAL)
Wintrust Financial Corporation (WTFC)
National Energy Services Reu SHS (NESR)
Ameris Ban (ABCB)
Columbia Banking System (COLB)
Alerus Finl (ALRS)
Meta Financial (CASH)
Carpenter Technology Corporation (CRS)
SkyWest (SKYW)
Preferred Bk Los Angeles Ca Com New (PFBC)

View all positions for Phocas Financial

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Portfolio Management
Wellington Management Company
UBS Group
State Street Corporation
Henderson Group
Vanguard Capital Management
Johnson & Johnson
Invesco
Jupiter Topco
Geode Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Protagonist Therapeutics